ASXL1 and Anophthalmia: Previous studies using Asxl1 KO mice have revealed developmental defects, including microcephaly, cleft palate, alveolar maturation defects, glomerular podocyte abnormalities, and anophthalmia (Abdel-Wahab et al. 2013; Moon et al. 2015; Moon et al. 2018).